PCN19 Cost-Effectiveness Analysis of Temsirolimus in Patients With Poor Risk Renal-Cell Carcinoma
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.316
https://www.valueinhealthjournal.com/article/S1098-3015(12)02029-3/fulltext
Section Title :
Cancer
Section Order :
1860
First Page :
A656
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02029-3&doi=10.1016/j.jval.2012.08.316